Scarica l'app Stockscreener
5.67
2.35%
0.13
Phathom Pharmaceuticals Inc Borsa (PHAT) Ultime notizie
How to Take Advantage of moves in (PHAT) - Stock Traders Daily
Phathom Pharmaceuticals CFO Molly Henderson sells shares worth $43,370 - MSN
Cantor Fitzgerald Begins Coverage on Phathom Pharmaceuticals (NASDAQ:PHAT) - MarketBeat
Phathom spikes as Cantor Fitzgerald bullish on IP claims - MSN
Cantor Fitzgerald Initiates Coverage on Phathom Pharmaceuticals (NASDAQ:PHAT) - Defense World
Phathom stock gains after Cantor bullish view (PHAT:NASDAQ) - Seeking Alpha
symbol__ Stock Quote Price and Forecast - CNN
Phathom Pharmaceuticals initiated at Cantor Fitzgerald on ‘significant’ upside - TipRanks
Cantor Fitzgerald Initiates Coverage on Phathom Pharmaceuticals With Overweight Rating, $23 Price Target - Marketscreener.com
Taking a Closer Look At Phathom Pharmaceuticals Inc (PHAT) Following Its Recent Trade - Knox Daily
Phathom Pharmaceuticals (PHAT) Stock Price, News & Analysis - MarketBeat
Stifel maintains $28 target on Phathom Pharmaceuticals stock - MSN
Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Shares Bought by Jennison Associates LLC - MarketBeat
Stifel maintains $28 target on Phathom Pharmaceuticals stock By Investing.com - Investing.com Canada
Phathom Pharmaceuticals Inc (PHAT) Stock: Assessing the Risk and Reward - The News Heater
The Future of Phathom Pharmaceuticals Inc: Analyzing PHAT - The InvestChronicle
Phathom Pharmaceuticals Inc [PHAT] CFO and CBO makes an insider sale of 6,583 shares worth $43371.0. - Knox Daily
Closing Strong: Phathom Pharmaceuticals Inc (PHAT) Ends at 5.63, Down -6.01 from Last Close - The Dwinnex
A stock that deserves closer examination: Phathom Pharmaceuticals Inc (PHAT) - US Post News
PHAT stock touches 52-week low at $6.06 amid market challenges - MSN
Further weakness as Phathom Pharmaceuticals (NASDAQ:PHAT) drops 12% this week, taking five-year losses to 81% - Simply Wall St
Phathom Pharmaceuticals to Present at the Guggenheim Securities SMID Cap Biotech Conference - GlobeNewswire
Phathom Pharmaceuticals to Present at the Guggenheim Securities SMID Cap Biotech Conference - GlobeNewswire Inc.
Exclusive: Phathom's Next-Gen GI Treatments Take Center Stage at Major Biotech Conference - StockTitan
Trading (PHAT) With Integrated Risk Controls - Stock Traders Daily
Phathom Pharmaceuticals Stock: A Comprehensive Analysis of Recent Developments - The Digital Weekly
Insider Selling: Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) COO Sells 7,886 Shares of Stock - MarketBeat
Insider Selling: Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) CFO Sells 6,583 Shares of Stock - MarketBeat
Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Insider Terrie Curran Sells 19,109 Shares - MarketBeat
Phathom Pharmaceuticals COO Nabulsi sells $51,956 in stock By Investing.com - Investing.com South Africa
Phathom Pharmaceuticals COO Nabulsi sells $51,956 in stock - MSN
Phathom Pharmaceuticals Executives Conduct Share Sales - TradingView
Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT): Are Analysts Optimistic? - Yahoo Finance
(PHAT) Technical Pivots with Risk Controls - Stock Traders Daily
Barclays PLC Buys 45,402 Shares of Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) - Defense World
Phathom Pharmaceuticals (NASDAQ:PHAT) Earns Buy Rating from Needham & Company LLC - Defense World
Phathom Pharmaceuticals' (PHAT) "Buy" Rating Reiterated at Needham & Company LLC - MarketBeat
(PHAT) Proactive Strategies - Stock Traders Daily
Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Shares Sold by Jane Street Group LLC - Defense World
Phathom Pharmaceuticals (NASDAQ:PHAT) Trading Down 6.9%Here's What Happened - MarketBeat
Barclays PLC Grows Holdings in Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) - Defense World
Geode Capital Management LLC Buys 56,871 Shares of Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) - Defense World
Phathom Pharmaceuticals (NASDAQ:PHAT) Trading 7.1% HigherWhat's Next? - MarketBeat
0.27%
3.05%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):